» Articles » PMID: 4702168

Intestinal Barrier Function in Hemorrhagic Shock

Overview
Journal J Surg Res
Specialty General Surgery
Date 1973 Apr 1
PMID 4702168
Citations 10
Authors
Affiliations
Soon will be listed here.
Citing Articles

Induction of gut proteasome activity in hemorrhagic shock and its recovery by treatment with diphenyldihaloketones CLEFMA and EF24.

Rao G, Houson H, Nkepang G, Yari H, Teng C, Awasthi V Am J Physiol Gastrointest Liver Physiol. 2018; 315(2):G318-G327.

PMID: 29746173 PMC: 6139642. DOI: 10.1152/ajpgi.00066.2018.


Reduction of venous pressure during the resection of liver metastases compromises enteric blood flow: IGFBP-1 as a novel biomarker of intestinal barrier injury.

Barbeiro H, Machado M, de Souza H, Pinheiro da Silva F, Machado M Clinics (Sao Paulo). 2017; 72(10):645-648.

PMID: 29160429 PMC: 5666439. DOI: 10.6061/clinics/2017(10)10.


Effect of liposome-encapsulated hemoglobin resuscitation on proteostasis in small intestinal epithelium after hemorrhagic shock.

Rao G, Yadav V, Awasthi S, Roberts P, Awasthi V Am J Physiol Gastrointest Liver Physiol. 2016; 311(1):G180-91.

PMID: 27288424 PMC: 4967179. DOI: 10.1152/ajpgi.00157.2016.


Hemorrhagic shock-induced cerebral bioenergetic imbalance is corrected by pharmacologic treatment with EF24 in a rat model.

Rao G, Xie J, Hedrick A, Awasthi V Neuropharmacology. 2015; 99:318-27.

PMID: 26232641 PMC: 4655172. DOI: 10.1016/j.neuropharm.2015.07.033.


Remediation of hemorrhagic shock-induced intestinal barrier dysfunction by treatment with diphenyldihaloketones EF24 and CLEFMA.

Yadav V, Hussain A, Sahoo K, Awasthi V J Pharmacol Exp Ther. 2014; 351(2):413-22.

PMID: 25204337 PMC: 4201268. DOI: 10.1124/jpet.114.217331.